BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Nephrostomy Market: Increasing Incidence of Lifestyle Related Diseases to Drive the Market

  Nephrostomy surgical procedure is used to remove blockage from the kidney. The global nephrostomy market is expected to grow in the near future.

  February 14, 2022

   · 

  4 min read
• Cleanroom Stationery Market: The Biopharmaceutical Industry Segment is Likely to Account for Major Share of the Market

  Cleanrooms are controlled environments with low levels of pollutants such as dust, microorganisms, and chemical vapors.

  February 14, 2022

   · 

  5 min read
• The Global Surgical Equipment Market Size to Expand at a Steady 4% CAGR by 2030

  Fact.MR – A Market Research and Competitive Intelligence Provider: The surgical equipment market is constantly seeing a wide range of growth and it is backed by higher inclination towards minimally invasive procedures.

  February 14, 2022

   · 

  6 min read
• Drug Development

  Oxurion Announces New Data on THR-149 Phase 2 Clinical Trial (“KALAHARI”) in DME at the Angiogenesis, Exudation, and Degeneration 2022 Conference

  Oxurion NV presented new data from Part A of its two-part Phase 2 Clinical Trial assessing THR-149 for treatment of diabetic macular edema at the Angiogenesis, Exudations, and Degeneration 2022 Meeting on February 11-12th.

  February 14, 2022

   · 

  6 min read
• Business

  Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

  The Russian Direct Investment Fund announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca’s vaccine and the first component of the Sputnik V coronavirus vaccine (Sputnik Lite).

  February 14, 2022

   · 

  3 min read
• Biotech Bay

  Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors

  Fluidigm Corporation (Nasdaq:FLDM) today filed with the U.S. Securities and Exchange Commission to consider and vote upon various items related to the proposed and previously announced strategic capital infusion from leading life sciences investors Casdin Capital, LLC.

  February 14, 2022

   · 

  10 min read
• Business

  FibroGen to Report Fourth Quarter and Full Year 2021 Financial Results

  FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2021 financial results on Monday, February 28 after the market close.

  February 14, 2022

   · 

  1 min read
• Business

  Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022

  Acasti Pharma Inc. today provided a business update and announced its operating and financial results for the third quarter of its fiscal 2022 ended December 31, 2021.

  February 14, 2022

   · 

  10 min read
• Business

  AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2021

  Applied Genetic Technologies Corporation today announced financial results for the quarter ended December 31, 2021.

  February 14, 2022

   · 

  15 min read
• Business

  Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer

  Avadel Pharmaceuticals plc today announced the appointment of Douglas Williamson, MBChB, as Chief Medical Officer.

  February 14, 2022

   · 

  5 min read